2026 年至 2035 年眼壓計市場的商業機會、成長要素、產業趨勢分析與預測。

2025 年全球眼壓計市場價值為 3.984 億美元，預計到 2035 年將達到 6.442 億美元，年複合成長率為 4.7%。

眼科疾病疾病盛行率的上升以及影響眼部健康的慢性疾病發生率的增加，推動了市場擴張。人們對預防醫學和早期診斷的認知不斷提高，促使更多人定期進行眼科檢查，從而顯著提升了對診斷設備的需求。眼科設備的科技進步，進一步提高了測量精度、易用性和患者舒適度，推動了眼壓計在醫療機構中的廣泛應用。專業眼科機構的擴建、保險報銷政策的完善以及人們對家庭監測解決方案日益成長的興趣，也促進了市場成長。隨著人們對早期發現視力相關疾病的重視程度不斷提高，眼壓測量作為常規診斷方法的重要性日益凸顯。隨著宣傳宣傳活動和病患教育工作的不斷深入，眼壓測量的應用越來越廣泛，從而支撐了全球醫療系統對這些設備的穩定需求。

至2025年，隱形眼鏡眼壓計市佔率將達到63.1%。這些設備通常在受控的臨床環境中使用，並由訓練有素的專業人員確保正確操作和消毒。在專業醫療機構的廣泛應用有助於實現精確測量和可靠的診斷結果，從而鞏固其市場地位。

2025年，壓平式眼壓計市場規模預計將達2.333億美元。由於其高精度和高一致性，這些設備被廣泛認為是眼壓測量的標準。它們在臨床診斷中的成熟應用多年來一直保持著強勁的需求。此外，它們與其他眼科檢查設備的兼容性提高了常規檢查的效率，進一步加速了其在醫療機構中的普及。

預計2025年，美國眼壓計市場規模將達到1.213億美元。該地區市場成長的驅動力在於先進診斷技術的快速普及，這些技術提高了診斷的準確性並改善了患者體驗。醫療機構正擴大將眼壓計系統與電子健康記錄平台整合，以簡化臨床工作流程。此外，支持性的醫療政策和人們對預防醫學日益成長的關注也進一步促進了定期眼科檢查，從而維持了對眼壓計產品的持續需求。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策及對資料完整性的承諾
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 研究路徑的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 青光眼和其他眼科疾病的發生率增加
    • 設備技術進步
    • 人們越來越重視眼部健康和早期診斷
    • 糖尿病患者數量增加
  • 產業潛在風險與挑戰
    • 感染風險和結果準確性不足
  • 機會
    • 人工智慧與數位眼科醫療保健平台的整合
• 成長潛力分析
• 監理情勢（基於初步調查）
• 科技與創新趨勢
  • 當前技術趨勢
  • 新興技術
• 未來市場趨勢（基於初步研究）
• 救贖方案
• 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
• 價格分析（2025 年）（基於初步調查）
• 差距分析
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析（基於初步研究）
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場估計與預測：依類型分類，2022-2035年

• 接觸式眼壓計
• 非接觸式眼壓計

第6章 市場估計與預測：依技術分類，2022-2035年

• 壓平式眼壓計
• 回彈式眼壓計
• 壓痕式眼壓計
• 其他技術

第7章 市場估計與預測：按性別分類的攜帶式設備市場，2022-2035年

• 桌面
• 手持式

第8章 市場估算與預測：依最終用途分類，2022-2035年

• 醫院
• 眼科診所
• 門診手術中心
• 其他最終用戶

第9章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Accutome（Keeler）
• Canon
• Costruzione Strumenti Oftalmici（CSO）
• HAAG-STREIT GROUP
• Huvitz
• Kowa
• MediWorks
• NIDEK
• OCULUS
• Reichert AMETEK
• Revenio Group（iCare）
• Rexxam
• TOMEY
• TOPCON
• ZEISS

The Global Tonometers Market was valued at USD 398.4 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 644.2 million by 2035.

Market expansion is driven by the increasing incidence of chronic conditions that impact eye health, along with the rising prevalence of ocular disorders. Growing awareness around preventive healthcare and early diagnosis is encouraging individuals to undergo routine eye examinations, which is significantly boosting demand for diagnostic devices. Technological progress in ophthalmic equipment is further enhancing device accuracy, usability, and patient comfort, making tonometers more widely adopted across healthcare settings. The expansion of specialized eye care facilities, supportive reimbursement structures, and rising interest in home-based monitoring solutions are also contributing to growth. Increased focus on early detection of vision-related conditions is reinforcing the importance of intraocular pressure measurement as a routine diagnostic practice. As awareness campaigns and patient education initiatives continue to expand, the use of tonometry is becoming more widespread, supporting consistent demand for these devices across global healthcare systems.

The contact tonometer segment held a share of 63.1% in 2025. These devices are commonly utilized in controlled clinical environments where trained professionals can ensure proper handling and sterilization. Their widespread use in specialized care settings supports accurate measurement and reliable diagnostic outcomes, contributing to their strong market presence.

The applanation tonometer segment generated USD 233.3 million in 2025. These devices are widely regarded as a benchmark for intraocular pressure measurement due to their high level of precision and consistency. Their established role in clinical diagnostics has sustained strong demand over time. Additionally, their compatibility with other ophthalmic examination tools enhances their efficiency during routine evaluations, further strengthening their adoption across medical facilities.

U.S. Tonometers Market was valued at USD 121.3 million in 2025. Market growth in the region is supported by the rapid adoption of advanced diagnostic technologies that improve both accuracy and patient experience. Healthcare providers are increasingly integrating tonometry systems with digital record platforms to streamline clinical workflows. Supportive healthcare policies and growing emphasis on preventive care are further encouraging routine eye examinations, contributing to sustained product demand.

Key companies operating in the Global Tonometers Market include Accutome (Keeler), Canon, Costruzione Strumenti Oftalmici (CSO), HAAG-STREIT GROUP, Huvitz, Kowa, MediWorks, NIDEK, OCULUS, Reichert AMETEK, Revenio Group (iCare), Rexxam, TOMEY, TOPCON, and ZEISS. Companies in the Tonometers Market are strengthening their competitive position through continuous product innovation and technological advancement. Many players are investing in the development of automated, non-invasive, and digitally integrated devices to enhance accuracy and patient comfort. Strategic collaborations with healthcare providers and distribution partners are helping expand market reach and improve accessibility. Firms are also focusing on integrating their devices with digital health platforms to support efficient data management and clinical workflows. Additionally, investments in research and development are enabling the introduction of advanced solutions tailored to evolving healthcare needs. Expanding global presence and enhancing after-sales support services are further supporting long-term growth and customer retention.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 Technology trends
  • 2.2.4 Portability trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of glaucoma and ocular diseases
    • 3.2.1.2 Technological advancements in devices
    • 3.2.1.3 Growing awareness towards eye health and early diagnosis
    • 3.2.1.4 Increase in number of diabetic patients
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Risk of infection and lack of accuracy in results
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration of AI and digital eye health platforms
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 MEA
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Reimbursement scenario
• 3.8 Impact of AI & generative AI on the market (Driven by Primary Research)
• 3.9 Pricing analysis, 2025 (Driven by Primary Research)
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Contact tonometer
• 5.3 Non-contact tonometer

Chapter 6 Market Estimates and Forecast, By Technology, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Applanation tonometer
• 6.3 Rebound tonometer
• 6.4 Indentation tonometer
• 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Portability, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Desktop
• 7.3 Handheld

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ophthalmic clinics
• 8.4 Ambulatory surgical centers
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Accutome (Keeler)
• 10.2 Canon
• 10.3 Costruzione Strumenti Oftalmici (CSO)
• 10.4 HAAG-STREIT GROUP
• 10.5 Huvitz
• 10.6 Kowa
• 10.7 MediWorks
• 10.8 NIDEK
• 10.9 OCULUS
• 10.10 Reichert AMETEK
• 10.11 Revenio Group (iCare)
• 10.12 Rexxam
• 10.13 TOMEY
• 10.14 TOPCON
• 10.15 ZEISS